| Amag Pharma Cutting 68 Jobs - Xconomy |
|
|
Xconomy“As our sales in the dialysis segment have begun to decline at a rate quicker than our growth in the non-dialysis chronic kidney disease segment, ...AMAG Finds Safety Issues with Feraheme, Cuts Workforce Renal Business Today (blog)Needham & Company Reiterates a 'Buy' on AMAG Pharmaceuticals (AMAG); 3Q10 ... read more |